Becton, Dickinson and Company (NYSE:BDX) Q4 2024 Earnings Call Transcript
Operator: Hello and welcome to BD's Fourth Quarter and Full Year Fiscal 2024 Earnings Call.
Becton Dickinson & Co (BDX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Generation Investment Management David Blood And Al Gore | 5,954,632 | $1,435,661,778 | +11% | 6.7% |
| 2. | First Eagle Investment Management Jean-Marie Eveillard | 3,368,143 | $812,059,195 | +21% | 1.67% |
| 3. | Diamond Hill Capital Ric Dillon | 1,434,559 | $345,872,175 | +1% | 1.39% |
| 4. | Impax Asset Management Ian Simm | 936,258 | $225,112,659 | -3% | 0.88% |
| 5. | Renaissance Technologies Jim Simons | 673,091 | $162,282,240 | +40% | 0.24% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $247.96 | 30 | Director | 10,052 | 2019-04-16 | Filing | |
| $239.01 | 45 | Director | 10,022 | 2018-06-22 | Filing | |
| $225.89 | 285 | Director | 9,977 | 2018-04-13 | Filing | |
| $225.07 | 500 | Director | 2,728 | 2018-05-07 | Filing | |
| $75.79 | 5,000 | Director | 33,791 | 2009-11-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $239.31 | 300 | Officer | 1,976 | 2024-06-10 | Filing | |
| $237.46 | 1,100 | Officer | 11,308 | 2024-05-15 | Filing | |
| $236.99 | 1,400 | Officer | 12,408 | 2024-05-15 | Filing | |
| $235.29 | 800 | Officer | 13,808 | 2024-05-15 | Filing | |
| $237.90 | 28 | Officer | 14,608 | 2024-05-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,123,070 | $6,369,588,157 | 0.13% | |
| 2. | 22,775,364 | $5,553,317,101 | 0.14% | |
| 3. | 12,915,202 | $3,149,113,704 | 0.15% | |
| 4. | 10,711,553 | $2,611,798,726 | 0.23% | |
| 5. | 6,672,346 | $1,626,918,126 | 0.3% |
News See All
8 Most Promising Medical Stocks According to Hedge Funds
The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.
Goldman Sachs' List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks
As the fourth quarter of 2024 starts, the market is once again back to debating about the Federal Reserve's interest rate cuts.
10 Best Dividend Aristocrats According to Wall Street Analysts
Shifts in investment trends have revealed new insights for investors in recent years.
10 Best Organ Transplant and Diagnosis Stocks To Buy Now
In the dynamic landscape of healthcare, the importance of organ transplantation cannot be overstated.
Becton, Dickinson and Company (NYSE:BDX) Q3 2024 Earnings Call Transcript
Operator: Hello and welcome to BD's Third Quarter Fiscal 2024 Earnings Conference Call.
Here’s Why Madison Investors Fund Sold Becton, Dickinson and Company (BDX)
Madison Investments, an investment advisor, released its “Madison Investors Fund” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
25 Best Dividend Aristocrats to Buy According to Analysts
The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm.
11 Best Recession Dividend Stocks To Buy
In this article, we discuss 11 best recession dividend stocks to buy.
Becton, Dickinson and Company (NYSE:BDX) Q2 2024 Earnings Call Transcript
Becton, Dickinson and Company beats earnings expectations. Reported EPS is $3.17, expectations were $2.97.